Prostate Cancer Susceptibility Polymorphism rs2660753 Is Not Associated with Invasive Ovarian Cancer

Ernest K Amankwah, Linda E Kelemen, Qinggang Wang, Honglin Song, Georgia Chenevix-Trench, Jonathan Beesley, Penelope M Webb, Celeste L Pearce, Anna H Wu, Malcolm C Pike, Daniel O Stram, Jenny Chang-Claude, Shan Wang-Gohrke, Roberta B Ness, Ellen L Goode, Julie M Cunningham, Brooke L Fridley, Robert A Vierkant, Shelley S Tworoger, Alice S WhittemoreValerie McGuire, Weiva Sieh, Simon A Gayther, Aleksandra Gentry-Maharaj, Usha Menon, Susan J Ramus, Mary Anne Rossing, Jennifer A Doherty, Marc T Goodman, Michael E Carney, Galina Lurie, Lynne R Wilkens, Susanne Krüger Kjær, Estrid Høgdall, Daniel W Cramer, Kathryn L Terry, Montserrat Garcia-Closas, Hannah Yang, Jolanta Lissowska, Hoda Anton-Culver, Argyrios Ziogas, Joellen M Schildkraut, Andrew Berchuck, Paul D P Pharoah, on behalf of the Australian Ovarian Cancer Study Group

    Fingerprint

    Dive into the research topics of 'Prostate Cancer Susceptibility Polymorphism rs2660753 Is Not Associated with Invasive Ovarian Cancer'. Together they form a unique fingerprint.

    Medicine & Life Sciences